Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-21

Clinical Trial Update: Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy [NA]

View source ↗

Summary

A terminated clinical trial evaluated vitamin E for LCHAD-associated neuropathy related to mitochondrial trifunctional protein deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin E (tocopherol)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Peripheral Neuropathy, Mitochondrial Trifunctional Protein Deficiency | NA | Status: TERMINATED